Background Post-acute coronavirus 2019 (COVID-19) syndrome is now recognized as a
complex systemic disease that is associated with substantial morbidity. Objectives To estimate …

More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …

Objectives Cytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated
with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our …

Background Emerging epidemiological evidence suggests that statin use may reduce the
risk of infections and infection-related complications. Our objective was to examine the …

Objectives Clinical studies of chloroquine (CQ) and hydroxychloroquine (HCQ) in COVID-19
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …

Background An increase in plasma n–3 fatty acid content, particularly eicosapentaenoic acid
(20:5n–3; EPA) and docosahexaenoic acid (22:6n–3; DHA), is observed after consumption …

This study assessed the potential therapeutic efficacy of adipose-derived stem cells (ASCs)
on infarcted hearts. Myocardial infarction was induced in rat hearts by occlusion of the left …

Background Many postmortem studies address the cardiovascular effects of COVID-19 and
provide valuable information, but are limited by their small sample size. Objectives The aim …

Background To systematically review the literature about the association between systemic
corticosteroid therapy (CST) and outcomes of COVID-19 patients. Methods We searched …

Platelet endothelial cell-adhesion molecule-1 (PECAM-1, CD31) is constitutively expressed
by vascular endothelium and concentrates at intercellular junctions. Regulation of PECAM-1 …